Entity
  • Ariana Pharma

    Created in 2003
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    2,902
  • Activities

  • Technologies

  • Entity types

  • Location

    60 Av. de la Grande Armée, 75017 Paris, France

    Paris

    France

  • Employees

    Scale: 11-50

    Estimated: 37

  • SIREN

    449727205
  • Engaged corporates

    6
    0 3
  • Added in Motherbase

    3 years, 9 months ago
Description
  • Value proposition

    The leading xAI-driven drug development company

    Ariana Pharma is a leading Artificial Intelligence (AI) drug development company. Using its KEM® Artificial Intelligence (xAI) technology, Ariana helps its partners introduce personalized medicine clinical trial design into their protocols and optimize clinical endpoints, identify biomarkers of therapeutic response and potential synergistic therapies. Ariana routinely collects and combines clinical data with omic data, immunological readouts (such as Fluorescence-Activated Cell Sorting (FACS)), microbiota, Patient Reported Outcomes (PRO) as well as Real World Evidence (RWE) data. Combining advanced data analytics, drug development, and regulatory expertise, Ariana helps translate findings into innovative clinical development plans and regulatory approvals. With a growing number of successful therapeutic development programs, KEM® is an FDA-assessed technology that systematically explores combinations of biomarkers, producing more effective biomarker signatures for precision medicine. Ariana has developed Onco KEM®, the most advanced, clinically tested, oncology therapeutic decision support system. Founded in 2003 as a spin-off of the Institut Pasteur, Paris, France, the company operates a subsidiary in the United States since 2012.

    Patient Stratification, Responder Analysis, Multi-objective lead optimization, Biomarker Development, Multiplex Biomarkers, Drug Safety, Drug Kit Optimization, and Personalized Medicine

  • Original language

    The leading xAI-driven drug development company

    Ariana Pharma is a leading Artificial Intelligence (AI) drug development company. Using its KEM® Artificial Intelligence (xAI) technology, Ariana helps its partners introduce personalized medicine clinical trial design into their protocols and optimize clinical endpoints, identify biomarkers of therapeutic response and potential synergistic therapies. Ariana routinely collects and combines clinical data with omic data, immunological readouts (such as Fluorescence-Activated Cell Sorting (FACS)), microbiota, Patient Reported Outcomes (PRO) as well as Real World Evidence (RWE) data. Combining advanced data analytics, drug development, and regulatory expertise, Ariana helps translate findings into innovative clinical development plans and regulatory approvals. With a growing number of successful therapeutic development programs, KEM® is an FDA-assessed technology that systematically explores combinations of biomarkers, producing more effective biomarker signatures for precision medicine. Ariana has developed Onco KEM®, the most advanced, clinically tested, oncology therapeutic decision support system. Founded in 2003 as a spin-off of the Institut Pasteur, Paris, France, the company operates a subsidiary in the United States since 2012.

  • Home - Ariana Pharma

    Artificial Intelligence and Precision Medicine design leading to accelerated drug development and expedited regulatory approval

  • https://www.arianapharma.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Genopole
Genopole
Biotechnology, Biotechnology Research
Genopole
Biotechnology, Biotechnology Research
Other

5 Jul 2024


Medicen Paris Region
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Other

5 Jul 2024


CCI Paris IdF
CCI Paris IdF
Chamber of commerce, Government Administration
CCI Paris IdF
Chamber of commerce, Government Administration
Other

5 Jul 2024


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Other

5 Jul 2024


STATION F
STATION F
Startup accelerator & VC, Software Development
STATION F
Startup accelerator & VC, Software Development
Other

20 Nov 2022


Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Other

24 Apr 2024


Similar entities
Loading...
Loading...
Social network dynamics